Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Mycobacterium tuberculosis F-ATP synthase c-ring is a critical component of the F0 sector of the ATP synthase enzyme complex, which is responsible for coupling proton transport across the bacterial membrane to the synthesis of ATP (Preiss et al., 2015, PNAS). It is composed of a ring of nine identical 'c' subunits, encoded by the atpE gene, that act as a rotary motor driven by the proton motive force (Koul et al., 2007, Nature Communications). This target is essential for the survival of Mycobacterium tuberculosis in both actively replicating and non-replicating (dormant) states, making it a unique and potent target for anti-tubercular therapy (Andries et al., 2005, Science). The diarylquinoline drug Bedaquiline targets this site by binding to specific residues on the c-subunits, effectively jamming the rotary mechanism and halting ATP production (Zhang et al., 2019, Nature). This mechanism is highly selective for mycobacterial ATP synthase over human mitochondrial ATP synthase, providing a therapeutic window for treating multi-drug resistant tuberculosis (FDA Sirturo Label; Haagsma et al., 2009, Proteins).
Binds to the c-ring of the F0 subunit of ATP synthase, physically blocking the rotation of the enzyme and inhibiting proton translocation, which leads to the depletion of cellular ATP levels (Andries et al., 2005, Science; Zhang et al., 2019, Nature).
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mycobacterium tuberculosis F-ATP synthase subunit c (AtpE).